Literature DB >> 15985215

Midkine regulates pleiotrophin organ-specific gene expression: evidence for transcriptional regulation and functional redundancy within the pleiotrophin/midkine developmental gene family.

Gonzalo Herradon1, Laura Ezquerra, Trang Nguyen, Inmaculada Silos-Santiago, Thomas F Deuel.   

Abstract

Midkine (MK) and the highly related cytokine pleiotrophin (PTN) constitute the PTN/MK developmental gene family. The Mk and Ptn genes are essential for normal development of the catecholamine and renin-angiotensin pathways and the synthesis of different collagens. It is not known whether the Ptn and Mk genes regulate each other or whether PTN and MK are functionally redundant in development. We have now compared the levels of expression of Ptn and Mk in genetically deficient Mk -/- and Ptn -/- mice and found highly significant increases in Ptn gene expression in spinal cord, dorsal root ganglia, eye, heart, aorta, bladder, and urethra, but not in brain, bone marrow, testis, and lung of Mk -/- mice compared with wild type mice; a remarkable approximately 230-fold increase in Ptn expression levels was found in heart of Mk -/- mice and highly significant but lesser increases were found in six other organs. Differences in levels of Mk gene expression in Ptn -/- mice could not be detected in any of the organs tested. The data demonstrate that MK regulates Ptn gene expression with a high degree of organ specificity, suggesting that Ptn gene expression follows Mk gene expression in development, that the increase in Ptn gene expression is compensatory for the absence of MK in Mk -/- mice, that PTN and MK share a high degree of functional redundancy, and that MK may be very important in the development of heart in mouse.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15985215     DOI: 10.1016/j.bbrc.2005.05.160

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  Structure and function of midkine as the basis of its pharmacological effects.

Authors:  T Muramatsu
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

2.  NPAS1 regulates branching morphogenesis in embryonic lung.

Authors:  Bernadette M Levesque; Shutang Zhou; Lin Shan; Pamela Johnston; Yanping Kong; Simone Degan; Mary E Sunday
Journal:  Am J Respir Cell Mol Biol       Date:  2006-11-16       Impact factor: 6.914

3.  The regulatory utilization of genetic redundancy through responsive backup circuits.

Authors:  Ran Kafri; Melissa Levy; Yitzhak Pilpel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-21       Impact factor: 11.205

Review 4.  The midkine family of growth factors: diverse roles in nervous system formation and maintenance.

Authors:  C Winkler; S Yao
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

5.  Role of midkine-progranulin interaction during angiogenesis of hepatocellular carcinoma.

Authors:  Huilian Huang; Jing Li; Yongliang Lu; Lishan Min; Dongli Li; Licheng Dai
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 6.  Pleiotrophin: Activity and mechanism.

Authors:  Xu Wang
Journal:  Adv Clin Chem       Date:  2020-03-12       Impact factor: 5.394

Review 7.  Targeting midkine and pleiotrophin signalling pathways in addiction and neurodegenerative disorders: recent progress and perspectives.

Authors:  G Herradón; C Pérez-García
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 8.  From top to bottom: midkine and pleiotrophin as emerging players in immune regulation.

Authors:  Noah Sorrelle; Adrian T A Dominguez; Rolf A Brekken
Journal:  J Leukoc Biol       Date:  2017-03-29       Impact factor: 4.962

Review 9.  The role of pleiotrophin and beta-catenin in fetal lung development.

Authors:  Tingting Weng; Lin Liu
Journal:  Respir Res       Date:  2010-06-18

Review 10.  Anaplastic lymphoma kinase: signalling in development and disease.

Authors:  Ruth H Palmer; Emma Vernersson; Caroline Grabbe; Bengt Hallberg
Journal:  Biochem J       Date:  2009-05-27       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.